BlackBerry shares tumble on sales shortfall in largest business
(Reuters) - Canada's BlackBerry Ltd on Wednesday reported lower-than-expected sales for its biggest business, hurt by weak demand for its security software from firms and government agencies, sending its shares down as much as 10%. Waterloo, Ontario-based BlackBerry, once known for its phones, has pivoted to selling software such as those used in mobiles and by automakers, hoping to find a more stable source of revenue. The company also supplies technology to companies developing driverless cars
(Reuters) - Canada's BlackBerry Ltd on Wednesday reported lower-than-expected sales for its biggest business, hurt by weak demand for its security software from firms and government agencies, sending its shares down as much as 10%.
Waterloo, Ontario-based BlackBerry, once known for its phones, has pivoted to selling software such as those used in mobiles and by automakers, hoping to find a more stable source of revenue. The company also supplies technology to companies developing driverless cars.
But revenue from its Internet of Things business, which houses its enterprise software and technology solutions, rose only 5% to $137 million, coming in below estimates of $151.4 million, according to IBES data from Refinitiv.
"IoT appeared to have underperformed. Given (technology solutions) revenue stream is typically stable and growing, any shortfall would have been from enterprise software," Raymond James analyst Steven Li said.
Overall adjusted revenue rose 23% to $267 million in the first quarter, benefiting from the company's recent $1.4 billion bet on cybersecurity firm Cylance.
"Excluding Cylance, revenue was down slightly," Li said.
BlackBerry in February completed its acquisition of California-based Cylance, whose software uses machine learning to preempt security breaches.
In the quarter, adjusted revenue from Cylance was $51 million, above the average analyst estimate of $48.8 million.
The company's net loss narrowed to $35 million, or 9 cents per share, in the quarter ended May 31, from $60 million, or 11 cents per share, a year earlier.
Excluding one-time items, the company earned 1 cent per share, in line with analysts' estimates.
BlackBerry's shares were last down 8.6% at C$9.95.
(Reporting by Debroop Roy in Bengaluru; Editing by Maju Samuel and Sweta Singh)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment
SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.
CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.